logo

Biotechnology & Drugs News

Share

Roche Announces Changes In Board Of Directors; Andreas Oeri To Retire From Board

Novartis Announces Data From 52-week Pivotal Phase III PALLADIUM Trial

Lexicon Announces Positive Topline Data From Phase 1 Study Of LX9211

GlaxoSmithKline: ViiV Healthcare Submits NDA To FDA For Fostemsavir

Novartis Holds An Investor Event In London; Expects To Sustain Long-term Growth

Novartis Says Tender Offer For The Medicines Co. Begins

>